论文部分内容阅读
难治性心力衰竭是各科心脏病所致的中末阶段,本院心内科对50例难治性心衰患者,在常规治疗的基础上,采用硝普钠联合多巴酚丁胺、多巴胺和速尿治疗,疗效显著,报告如下。1临床资料按照难治性心力衰竭的判断标准确诊50例。经休息、吸氧、限钠饮食、足量洋地黄、利尿剂、A- CEI、硝酸酯类等治疗1W后,按NYHA心功能分级仍属Ⅲ、Ⅳ级者。其中男33例,女17例;年龄35岁～79岁,平均65岁。其中高血压心脏病22例,冠心病15例,冠心病并发高血压心脏病8例,肺心病4例,风心病1例。
Refractory heart failure is caused by heart disease in the end stage, the hospital cardiology of 50 patients with refractory heart failure, on the basis of conventional treatment, the use of sodium nitroprusside combined dobutamine, dopamine And furosemide treatment, a significant effect, the report is as follows. 1 clinical data according to the criteria of refractory heart failure diagnosed 50 cases. After rest, oxygen, limited sodium diet, adequate digitalis, diuretics, A-CEI, nitrates and other treatment 1W, according to NYHA heart function classification is still Ⅲ, Ⅳ grade. Including 33 males and 17 females; aged 35 to 79 years, mean 65 years. Among them, 22 were hypertensive heart disease, 15 were coronary heart disease, 8 were coronary heart disease and hypertension heart disease, 4 were pulmonary heart disease and 1 was rheumatic heart disease.